Among patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor fails to meet prespecified noninferiority criteria compared with ...
Generations have grown up opening baseball card packs and blind boxes and bags, and then trading and selling the items they ...
Risk-bearing provider organizations rely on physicians to achieve cost savings. The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...
Adding almonds to the diet of adults with obesity enhances inflammatory cytokine profiles and diet quality, highlighting a ...
In a recent video interview with Applied Clinical Trials, Marc Buyse, ScD, founder and CEO of IDDI, discussed how growing trial complexity is creating new challenges for data conf ...
In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, reflects on the gap between sponsor expectations and statistical reality, drawing on lessons from the COVID era to argue for more ...
Stop falling for misleading headlines. Understand the difference between correlation and causation, and learn how researchers prove real scientific facts.
This is a shame, because regular exercise is really beneficial. It can control high blood pressure, improve mental health and reduce falls among older adults. A review of 187 randomized controlled ...
This transition is explored in “Embodied Artificial Intelligence in Healthcare: A Systematic Review of Robotic Perception, ...
How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...
Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2025 Earnings Call Transcript March 12, 2026 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.15451 EPS, expectations ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果